subcutaneous – ASH 2017 Blogs

Menu

Home
Social Media Team
ASH 2017 Abstracts
Videos from ASH 2017
IMF Website

Home
Social Media Team
ASH 2017 Abstracts
Videos from ASH 2017
IMF Website

Another SubQ Option on Its Way

December 14, 2017 | Michael Tuohy

I remember well in 2015, we had monumental FDA approvals of Kyprolis in July, followed by Darzalex, Ninlaro and Elotuzumab in November (also known as the November to Remember!) This year at ASH, each of these approved drugs continued to have new trials using them in a variety of combinations. I am impressed with Darzalex [...]

Popular
Recent
Comments
Tags

New Things To Learn at ASHThe 59th Annual American Society of Hematology (#ASH17) meeting is [...]
Knowledge Empowers UsIn 2008 I attended my first International Myeloma Foundation (IMF) [...]
Myeloma Journey: My Version of an Ironman CompetitionI’m honored to be a patient representative of the International [...]
What Can Patients Learn at ASH?Soon I’ll be off to Atlanta the site of this [...]

My 2017 ASH FindingsA new member of our Santa Fe support group sent [...]
Disparities in Advanced DirectivesI experienced four days of intense scientific meetings with some [...]
Hashtags, Tweets, and Blogs at #ASH2017Social media is everywhere! It’s a way for all of [...]
ASH 2017: Patients' Perspectives - Yelak Biru and Jack AielloIn this video Yelak Biru and Jack Aiello provides a [...]

abstracts B-cell maturation antigen BCMA CAR-T CAR-T cell CAR-T cell therapy daratumumab darzalex Dr. S. Vincent Rajkumar flu vaccine IMF Satellite Symposium imwg conference series Jack Aiello John DeFlice Laura Mooney levofloxacin Linda Huguelet mAb's Michael Tuohy minimal residual disease monoclonal antibodies MRD myeloma journey novel therapies November to Remember Quality of Life Robin Tuohy snow Teresa Miceli Tiffany Williams

Latest Posts from ASH2017
IMF Social Media Team
IMF at ASH17
My Tweets

THIS WEBSITE IS HOSTED BY THE INTERNATIONAL MYELOMA FOUNDATION ("IMF") FOR MULTIPLE MYELOMA SUPPORT GROUPS. THE CONTENT APPEARING ON THIS WEBPAGE IS NOT CONTROLLED OR PROVIDED BY IMF, AND IMF NEITHER WARRANTS NOR GUARANTEES THE ACCURACY OF SUCH CONTENT. THE FOREGOING NOTWITHSTANDING, THE CONTENT IS NOT A SUBSTITUTE FOR ADVICE AND SERVICE PROVIDED BY QUALIFIED AND LICENSED MEDICAL PROFESSIONALS, AND SHOULD NOT BE RELIED ON WITH RESPECT TO ANY HEALTH MATTERS. ANY HEALTH-RELATED INFORMATION FOUND HEREIN IS ONLY MADE AVAILABLE AS PART OF A GENERAL EDUCATIONAL SERVICE.

With support from: